General MedicationsINJECTIONGeneric

RANITIDINE HYDROCHLORIDE

Standard Dose

EQ 25MG BASE/ML

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview RANITIDINE HYDROCHLORIDE is listed in Drugs@FDA under application 091534 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient RANITIDINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 25MG BASE/ML Sponsor ZYDUS PHARMS USA INC Submission history Latest submission status date: 2013-07-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview RANITIDINE HYDROCHLORIDE is listed in Drugs@FDA under application 091534 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient RANITIDINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 25MG BASE/ML Sponsor ZYDUS PHARMS USA INC Submission history Latest submission status date: 2013-07-17 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.